Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

TNXP Tonix Pharmaceuticals Holding Corporation

0,1799

0,0004 (0,22%)

Vor Marktöffnung

Zuletzt aktualisiert: 14:39:55

Verzögert um 15 Minuten

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

null

Tonix Pharmaceuticals (NASDAQ:TNXP)
Historical Stock Chart
Von Mär 2024 bis Apr 2024

Click Here for more Tonix Pharmaceuticals Charts.

Tonix Pharmaceuticals (NASDAQ:TNXP)
Historical Stock Chart
Von Apr 2023 bis Apr 2024

Click Here for more Tonix Pharmaceuticals Charts.

News Tonix Pharmaceuticals Holding Corporation

Tonix Pharmaceuticals Announces Presentation at Planet MicroCap Showcase
Mittwoch 24 April 2024 (6 Tage vor) • GlobeNewswire Inc.

Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
Montag 1 April 2024 (4 Wochen vor) • GlobeNewswire Inc.

Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct Offering
Donnerstag 28 März 2024 (1 Monat vor) • GlobeNewswire Inc.

Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the Treatment of Prader-Willi Syndrome
Montag 25 März 2024 (1 Monat vor) • GlobeNewswire Inc.

Tonix Pharmaceuticals Announces Poster Presentation Describing Discovery of Novel Next-Generation Oxytocin Analogues at the American Chemistry Society (ACS) Spring 2024 Meeting
Donnerstag 21 März 2024 (1 Monat vor) • GlobeNewswire Inc.

Tonix Pharmaceuticals Announces Selection of Two Contract Manufacturing Organizations for the Launch and Commercial Manufacture of Tonmya™ for the Management of Fibromyalgia
Mittwoch 20 März 2024 (1 Monat vor) • GlobeNewswire Inc.

Tonix Pharmaceuticals Announces Transition to Fully Integrated Biopharmaceutical Company Expected on April 1, 2024
Dienstag 19 März 2024 (1 Monat vor) • GlobeNewswire Inc.

Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring
Dienstag 12 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Montag 11 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Tonix Pharmaceuticals Reports Improvement in “Brain Fog,” in Fibromyalgia Patients Treated with Tonmya™ in RESILIENT, an NDA-Enabling Phase 3 Clinical Trial, at the 6th International Congress on Controversies in Fibromyalgia
Montag 11 März 2024 (2 Monate vor) • GlobeNewswire Inc.

New to The Street Announces TV Episode 560 with its Five Business Guest Interviews, Airs as Sponsored Programming on Bloomberg TV Tonight, Thursday, March 7, 2024, at 9:30 PM PT
Donnerstag 7 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Donnerstag 7 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere Tonix Pharmaceuticals Holding Corporation News-Artikel

Financial Select Sector

Deutsche Lufthansa

Deutsche Telekom (QX)

Euro vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen